Status:
TERMINATED
Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy
Lead Sponsor:
Jonsson Comprehensive Cancer Center
Conditions:
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This research trial studies the effect of radiation therapy on tumor immunity. Standard radiation therapy destroys tumor cells. In response to tumor cell death caused by radiation therapy, the body ha...
Detailed Description
PRIMARY OBJECTIVES: I. To assess the effect of radiation therapy on tumor immunity. OUTLINE: Samples of blood are collected before, during, and within two weeks after radiation therapy and then sto...
Eligibility Criteria
Inclusion
- Signed and dated Institutional Review Board (IRB)-approved Informed Consent form for the study
- Received an explanation of the study, including satisfactory answers to all questions related to the proposed research
- Is undergoing physician directed radiation treatment
Exclusion
- The potential Subject is unwilling or hesitant to participate for any reason and/or fails to complete the appropriate Informed Consent form
Key Trial Info
Start Date :
July 8 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 9 2022
Estimated Enrollment :
139 Patients enrolled
Trial Details
Trial ID
NCT02310594
Start Date
July 8 2010
End Date
August 9 2022
Last Update
August 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jonsson Comprehensive Cancer Center
Los Angeles, California, United States, 90095